Aarti Drugs (India) Buy Hold or Sell Recommendation
| AARTIDRUGS | 356.60 23.40 7.02% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Aarti Drugs Limited is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Aarti Drugs Limited within the specified time frame.
Check out Aarti Drugs Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Aarti and provide practical buy, sell, or hold advice based on investors' constraints. Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Aarti |
Execute Aarti Drugs Buy or Sell Advice
The Aarti recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aarti Drugs Limited. Macroaxis does not own or have any residual interests in Aarti Drugs Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aarti Drugs' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Aarti Drugs Trading Alerts and Improvement Suggestions
| Aarti Drugs Limited generated a negative expected return over the last 90 days | |
| Aarti Drugs Limited is unlikely to experience financial distress in the next 2 years | |
| About 61.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Aarti Drugs Faces Significant Volatility Amid Declining Sales and Market Performance - MarketsMojo |
Aarti Drugs Returns Distribution Density
The distribution of Aarti Drugs' historical returns is an attempt to chart the uncertainty of Aarti Drugs' future price movements. The chart of the probability distribution of Aarti Drugs daily returns describes the distribution of returns around its average expected value. We use Aarti Drugs Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aarti Drugs returns is essential to provide solid investment advice for Aarti Drugs.
| Mean Return | -0.34 | Value At Risk | -3.91 | Potential Upside | 4.44 | Standard Deviation | 2.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aarti Drugs historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aarti Drugs Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (891.8M) | (1.1B) | 58.2M | 342.5M | 308.2M | 323.6M | |
| Change In Cash | 20.4M | 128.0M | (132.3M) | (7.6M) | (8.7M) | (8.3M) | |
| Free Cash Flow | 667.2M | (823.4M) | (304.7M) | 1.3B | 1.5B | 1.6B | |
| Depreciation | 498.8M | 500.5M | 503.2M | 514.5M | 591.6M | 367.1M | |
| Other Non Cash Items | (779.6M) | (630.2M) | (248.4M) | 332.7M | 299.5M | 314.4M | |
| Dividends Paid | 232.1M | 95.1M | 94M | 92.7M | 106.6M | 104.7M | |
| Capital Expenditures | 881.3M | 1.5B | 1.6B | 2.3B | 2.6B | 2.7B | |
| Net Income | 3.7B | 2.7B | 2.2B | 1.7B | 2.0B | 1.3B | |
| End Period Cash Flow | 88.1M | 216.1M | 83.8M | 67.4M | 77.5M | 68.2M | |
| Investments | (716.8M) | (1.5B) | (1.6B) | (2.2B) | (2.0B) | (1.9B) | |
| Net Borrowings | (1.5B) | (349.7M) | 2.0B | 613.7M | 705.8M | 741.1M | |
| Change To Netincome | 411.0M | 106.5M | 19.0M | 330.3M | 297.2M | 284.1M |
Aarti Drugs Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aarti Drugs or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aarti Drugs' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aarti stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.31 | |
β | Beta against Dow Jones | 0.43 | |
σ | Overall volatility | 2.90 | |
Ir | Information ratio | -0.09 |
Aarti Drugs Volatility Alert
Aarti Drugs Limited exhibits very low volatility with skewness of 1.81 and kurtosis of 6.43. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aarti Drugs' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aarti Drugs' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Aarti Drugs Fundamentals Vs Peers
Comparing Aarti Drugs' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aarti Drugs' direct or indirect competition across all of the common fundamentals between Aarti Drugs and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aarti Drugs or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aarti Drugs' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aarti Drugs by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aarti Drugs to competition |
| Fundamentals | Aarti Drugs | Peer Average |
| Return On Equity | 0.12 | -0.31 |
| Return On Asset | 0.0617 | -0.14 |
| Profit Margin | 0.07 % | (1.27) % |
| Operating Margin | 0.11 % | (5.51) % |
| Current Valuation | 35.97 B | 16.62 B |
| Shares Outstanding | 91.27 M | 571.82 M |
| Shares Owned By Insiders | 60.52 % | 10.09 % |
| Shares Owned By Institutions | 10.41 % | 39.21 % |
| Price To Book | 2.38 X | 9.51 X |
| Price To Sales | 1.38 X | 11.42 X |
| Revenue | 25.09 B | 9.43 B |
| Gross Profit | 8.09 B | 27.38 B |
| EBITDA | 3.2 B | 3.9 B |
| Net Income | 1.71 B | 570.98 M |
| Total Debt | 5.64 B | 5.32 B |
| Book Value Per Share | 139.96 X | 1.93 K |
| Cash Flow From Operations | 3.59 B | 971.22 M |
| Earnings Per Share | 16.63 X | 3.12 X |
| Target Price | 465.0 | |
| Number Of Employees | 1.06 K | 18.84 K |
| Beta | 0.88 | -0.15 |
| Market Capitalization | 32.15 B | 19.03 B |
| Total Asset | 24.32 B | 29.47 B |
| Retained Earnings | 11.55 B | 9.33 B |
| Working Capital | 5.25 B | 1.48 B |
| Annual Yield | 0 % | |
| Net Asset | 24.32 B | |
| Last Dividend Paid | 1.0 |
Aarti Drugs Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aarti . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2733.96 | |||
| Daily Balance Of Power | 3.492537 | |||
| Rate Of Daily Change | 1.07 | |||
| Day Median Price | 355.35 | |||
| Day Typical Price | 355.77 | |||
| Price Action Indicator | 12.95 | |||
| Period Momentum Indicator | 23.4 | |||
| Relative Strength Index | 35.8 |
About Aarti Drugs Buy or Sell Advice
When is the right time to buy or sell Aarti Drugs Limited? Buying financial instruments such as Aarti Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aarti Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.